Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Am J Hematol. 2020 Mar 30;95(6):662–671. doi: 10.1002/ajh.25781

FIGURE 2.

FIGURE 2

Event free survival and overall survival (OS) of older AML patients after induction and consolidation chemotherapy with microtransplantation (MST). Improved survival measures were observed in patients with standard vs high risk cytogenetic features as per MRC/NCRI classification